Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 28, 2019; 25(48): 6902-6915
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6902
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6902
Figure 3 Relationship between cancer susceptibility candidate 9 and patients’ survival.
A: The overall survival of patients; B: The 1-year survival of patients in the high and low Cancer susceptibility candidate 9 (CASC9) expression groups (P = 0.049); C: The 3-year survival of patients in the high and low CASC9 expression groups (P = 0.041); D: The 5-year survival of patients in the high and low CASC9 expression groups (P = 0.004). CASC9: Cancer susceptibility candidate 9.
- Citation: Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol 2019; 25(48): 6902-6915
- URL: https://www.wjgnet.com/1007-9327/full/v25/i48/6902.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i48.6902